Heart attacks remain a leading cause of death and disability worldwide. The permanent loss of heart muscle cells—known as ...

Eli Lilly's Mounjaro diabetes drug has demonstrated superior performance over Trulicity in reducing heart attack and stroke ...

C-reactive protein (CRP) is produced by the liver in response to inflammation, signaling potential health issues.

Scientists at Northwestern University and University of California San Diego have developed a new, potent injectable therapy that can protect the heart from damage after a heart attack. The ...

Centers for Disease Control and Prevention figures indicate that in the US, 6.7 million people over the age of 20 years have heart failure (HF), which occurs when the heart is unable to pump ...

After a heart attack, this process of degradation has to be stopped so that tissues can health better. The protein-like polymer, or PLP, platform is made from a polymer that mimics Nrf2.

A leftover from microbes’ meals is linked to early heart disease in people. In mice, it contributed to plaque buildup in the arteries.

A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and strokes – something no existing treatment has been able to do. Despite a significant ...